# The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease

> **NCT02107144** · PHASE4 · COMPLETED · sponsor: **Clinical Hospital Center Zemun** · enrollment: 71 (actual)

## Conditions studied

- Coronary Artery Disease
- Microcirculation
- Vascular Resistance

## Interventions

- **DRUG:** trimetazidine

## Key facts

- **NCT ID:** NCT02107144
- **Lead sponsor:** Clinical Hospital Center Zemun
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02107144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02107144, "The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02107144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*